Evaluation of Dupilumab in Children With Uncontrolled Asthma

NCT02948959 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Dupilumab
DRUG: Placebo
DRUG: Asthma Controller Therapies
DRUG: Asthma Reliever Therapies

Sponsor

Sanofi

Collaborators

[object Object]